Showing results (2131-2140 of 2,548) with videos related to

Sort By:
Pageof 255
ERJ Open Research|October 26, 2022
Focused lung ultrasound to predict respiratory failure in patients with symptoms of COVID-19: a multicentre prospective cohort studySøren Helbo Skaarup, Rasmus Aagaard, Stig Holm Ovesen, et al.
European Heart Journal|April 10, 2009
Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 hMartin Busk, Anne Kaltoft, Søren S Nielsen, et al.
Nature Communications|July 20, 2024
LGR signaling mediates muscle-adipose tissue crosstalk and protects against diet-induced insulin resistanceOlga Kubrak, Anne F Jørgensen, Takashi Koyama, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced 225AcCaterina F Ramogida, Andrew K H Robertson, Una Jermilova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2018
Three-Hour Delayed Imaging Improves Assessment of Coronary 18F-Sodium Fluoride PETJacek Kwiecinski, Daniel S Berman, Sang-Eun Lee, et al.
International Journal of Cardiology|December 7, 2025
The association between self-reported frailty status and 1-year all-cause mortality and readmission following PCI: A prospective multi-centre cohort study, CONCARDPCIHanne Pilunnguaq Magdaline Marie Rasmussen Kreutzmann, Pernille Palm, Trine Bernholdt Rasmussen, et al.
Journal for Immunotherapy of Cancer|January 16, 2026
Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumorsIgnacio Melero, Neeltje Steeghs, Ulrik Lassen, et al.
BMC Health Services Research|April 1, 2021
Prehospital emergency medical technicians can perform ultrasonography and blood analysis in prehospital evaluation of patients with chronic obstructive pulmonary disease: a feasibility studyGiti Nadim, Christian B Laursen, Pia I Pietersen, et al.
Molecular Cancer|August 22, 2014
Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Contemporary Clinical Trials|December 24, 2023
Engaging carers in neuropsychological rehabilitation for brain cancer survivors: The "I'm aware: Patients And Carers Together" (ImPACT) programC R Buskbjerg, A Amidi, A Munk, et al.
Pageof 255